The Trump administration released new dietary guidelines on Wednesday, pushing Americans to prioritize protein and cut back ...
“Today marks a decisive change in federal nutrition policy,” the health secretary, Robert F. Kennedy Jr., said at a briefing ...
Obesity and diabetes treatment is undergoing a revolution with the advent of GLP-1 drugs, which help manage weight, control ...
Novo Nordisk A/S launches oral Wegovy in the U.S. with aggressive pricing as China patent expiry looms. Click for this ...
Pharmaceutical Technology on MSN
How one US state is tackling the drug affordability crisis
Maryland’s Prescription Drug Affordability Board (PDAB) serves as a bellwether for how other states may address high drug ...
Zacks Investment Research on MSN
LLY up 28% in 3 months: Is it the right time to invest in the stock?
Eli Lilly and Company’s LLY stock has risen 28% in the past three months. With exceptional growth from its GLP-1 drugs, ...
One of the most immediate impacts of AI in medical genetics lies in diagnosis, particularly for rare and complex genetic ...
Zacks Investment Research on MSN
Here's how VKTX's obesity drug is moving quickly through phase III
Viking Therapeutics VKTX is one of the few companies with a late-stage obesity candidate in its pipeline. The company is ...
Background Malnutrition influences prognosis in patients with heart failure, but current nutritional evaluation methods are ...
Background Axial spondyloarthritis (axSpA) impairs trunk strength, mobility and cardiorespiratory fitness. Despite exercise ...
Objective To characterise the age-related impact of organ damage patterns on health-related quality of life (HRQoL) in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback